From formulation to packaging, we provide personalized guidance at every step
Patients with severe renal disease, history of medullary thyroid cancer, multiple endocrine neoplasia type 2, pancreatitis, or severe gastrointestinal conditions should consult a provider before starting
Conclusion Switching from tirzepatide to retatrutide requires thoughtful planning and oversight
Starting at a low dose and gradually titrating upward, as recommended in prescribing guidelines, helps minimize gastrointestinal symptoms
metformin, SGLT2i or thiazolidinedione with or without sulphonylurea in PIONEER 7
Ive had great success in switching my patients to Voquezna, which offers a pharmacologic advantage in general - but especially when patients are struggling with the burden of BID PPIs or PPI + H2RA regimens